AtriCure (ATRC) Total Non-Current Liabilities (2010 - 2026)
AtriCure (ATRC) reported Total Non-Current Liabilities of $145.0 million for Q1 2026, up 6.76% year-over-year from $135.8 million in Q1 2025, and down 6.41% quarter-over-quarter from $154.9 million in Q4 2025.
AtriCure (ATRC) Total Non-Current Liabilities (2010 - 2026) Analysis & Trends
AtriCure (ATRC) has 17 years of Total Non-Current Liabilities data on file, last reported at $145.0 million in Q1 2026.
- Total Non-Current Liabilities for Q1 2026 came in at $145.0 million, up 6.76% year-over-year; the trailing twelve-month figure through Mar 2026 was $145.0 million (up 6.76% YoY), and the FY2025 annual result was $154.9 million, up 5.27% from the prior year.
- Total Non-Current Liabilities eased to $145.0 million in Q1 2026 per ATRC's latest filing, from $154.9 million in the prior quarter.
- Over five years, Total Non-Current Liabilities peaked at $154.9 million in Q4 2025 and troughed at $120.9 million in Q1 2022.
- A 5-year average of $137.8 million and a median of $135.8 million in 2025 frame the typical range for Total Non-Current Liabilities.
- The sharpest annual moves came in 2022 and 2023: Total Non-Current Liabilities fell 2.2% in 2022, then climbed 14.95% in 2023.
- A 5-year view of Total Non-Current Liabilities shows it stood at $127.5 million in 2022, then grew by 14.95% to $146.5 million in 2023, then increased by 0.42% to $147.1 million in 2024, then grew by 5.27% to $154.9 million in 2025, then slipped by 6.41% to $145.0 million in 2026.
- Business Quant data shows ATRC's Total Non-Current Liabilities at $145.0 million in Q1 2026, $154.9 million in Q4 2025, and $151.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 1.91 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 24.24 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 17.13 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 941.16 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 1.03 Bn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 8.65 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 3.98 Bn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 2.10 Bn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 12.54 Bn |
| 10 | AtriCure | 1.34 Bn | 1.19 Bn | 109.31 Mn | 144.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 144.98 Mn |
| Dec 31, 2025 | 154.90 Mn |
| Sep 30, 2025 | 151.57 Mn |
| Jun 30, 2025 | 143.19 Mn |
| Mar 31, 2025 | 135.79 Mn |
| Dec 31, 2024 | 147.15 Mn |
| Sep 30, 2024 | 148.84 Mn |
| Jun 30, 2024 | 134.00 Mn |
| Mar 31, 2024 | 134.07 Mn |
| Dec 31, 2023 | 146.53 Mn |
| Sep 30, 2023 | 136.21 Mn |
| Jun 30, 2023 | 130.53 Mn |
| Mar 31, 2023 | 127.02 Mn |
| Dec 31, 2022 | 127.47 Mn |
| Sep 30, 2022 | 130.38 Mn |
| Jun 30, 2022 | 129.46 Mn |
| Mar 31, 2022 | 120.93 Mn |
| Dec 31, 2021 | 130.34 Mn |
| Sep 30, 2021 | 122.22 Mn |
| Jun 30, 2021 | 123.48 Mn |